Anticoagulation Market to Touch USD 61.49 Billion by 2030 owing to Increasing Prevalence of Cardiovascular Diseases across the Globe | Research by SNS Insider
03 avr. 2023 11h05 HE
|
SNS Insider pvt ltd
Pune, April 03, 2023 (GLOBE NEWSWIRE) -- As per the report by SNS Insider, the Anticoagulation Market had a worth of USD 35.25 billion in 2022, and is anticipated to attain USD 61.49 billion by...
Anticoagulation protocol reduces venous thromboembolisms in patients with traumatic brain injury
26 mars 2020 12h00 HE
|
The Joint Commission
Study in April 2020 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., March 26, 2020 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) is one of the leading...
On-X LTI Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring
26 févr. 2013 08h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Feb. 26, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the US Food & Drug Administration (FDA) to market the...
On-X LTI Launches Innovative Heart Valve Products at European Meeting in Barcelona
29 oct. 2012 08h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
22 oct. 2012 08h01 HE
|
On-X Life Technologies Inc.
If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
The On-X(R) Heart Valve Compares Favorably to Tissue Valves
23 mai 2012 09h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, May 23, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that results from a study comparing the On-X mechanical heart valve to tissue valves...
On-X Life Technologies Releases Expected Timelines for Reduced Anticoagulation Study Results at AATS
30 avr. 2012 07h59 HE
|
On-X Life Technologies Inc.
SAN FRANCISCO, April 30, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is releasing the expected timelines for the initial submission to the FDA of...